Abraham AS, Brooks BA & Eylath U (1992) The effects of chromium supplementation on serum glucose and lipids in patients with and without non–insulin–dependent diabetes. Metabolism 41, 768–771.
Althuis MD, Jordan NE, Ludington EA & Wittes JT (2002) Glucose and insulin responses to dietary chromium supplements: a meta–analysis. American Journal of Clinical Nutrition 76, 148–155.
Anderson RA (1994) Stress effects on chromium nutrition of humans and farm animals. In Proceedings of Alltech's Tenth Symposium on Biotechnology in the Feed Industry, pp.267–274 [TP Lyons and KA Jacques editors]. Nottingham, UK: University Press.
Anderson RA (1997) Chromium as an essential nutrient for humans. Regulatory Toxicology and Pharmacology 26, S35–S41.
Anderson RA (1998a) Chromium, glucose intolerance and diabetes. Journal of the American College of Nutrition 17, 548–555.
Anderson RA (1998b) Effects of chromium on body composition and weight loss. Nutrition Reviews 56, 266–270.
Anderson RA (2002) Insulin, glucose intolerance and diabetes: Recent data regarding the chromium connection. Trace Elements Nutritional Health and Disease Proceedings 1, 79–86.
Anderson RA, Bryden NA & Polansky MM (1997a) Lack of toxicity of chromium chloride and chromium picolinate in rats. Journal of the American College of Nutrition 16, 273–279.
Anderson RA, Bryden NA, Polansky MM & Thorp JW (1991) Effect of carbohydrate loading and underwater exercise on circulating cortisol, insulin and urinary losses of chromium and zinc. European Journal of Applied Physiology 63, 146–150.
Anderson RA, Cheng N, Bryden NA, Polansky MM, Chi J & Feng J (1997b) Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46, 1786–1791.
Anderson RA & Kozlovsky AS (1985) Chromium intake, absorption and excretion of subjects consuming self–selected diets. American Journal of Clinical Nutrition 41, 1177–1183.
Anderson RA, Polansky MM, Bryden NA, Bhathena SJ & Canary JJ (1987) Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia. Metabolism 36, 351–355.
Anderson RA, Polansky MM, Bryden NA & Canary JJ (1991) Supplemental–chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low–chromium diets. American Journal of Clinical Nutrition 54, 909–916.
Anderson RA, Polansky MM, Bryden NA, Roginski EE, Patterson KY & Reamer DC (1982) Effect of exercise (running) on serum glucose, insulin, glucagon, and chromium excretion. Diabetes 31, 212–216.
Anderson RA, Roussel AM, Zouari N, Mahjoub S, Matheau JM & Kerkeni A (2001) Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. Journal of the American College of Nutrition 20, 212–218.
Borel JS, Majerus TC, Polansky MM, Moser PB & Anderson RA (1984) Chromium intake and urinary chromium excretion of trauma patients. Biological Trace Element Research 6, 317–326.
Brock JH (1985) Transferrins. In Metalloenzymes, vol.2, pp.183–262 [PM Harrison editor]. London, UK: MacMillan.
Cefalu WT, Bell-Farrow AD, Stegners J, Wang ZQ, King T, Morgan T & Terry JG (1999) Effect of chromium picolinate on insulin sensitivity in vivo. Journal of Trace Elements in Experimental Medicine 12, 71–84.
Cefalu WT, Wang ZQ, Zhang XH, Baldor LC & Russell JC (2002) Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut–4 translocation in obese, hyperinsulinemic (JCR–LA corpulent) rats. Journal of Nutrition 132, 1107–1114.
Chang X & Mowat DN (1992) Supplemental chromium for stressed and growing feeder calves. Journal of Animal Science 70, 559–565.
Davies S, McLaren HJ, Hunnisett A & Howard M (1997) Age–related decreases in chromium levels in 51,665 hair, sweat, and serum samples from 40,872 patients – implications for the prevention of cardiovascular disease and type II diabetes mellitus. Metabolism 46, 469–473.
Davis CM, Sumrall KH & Vincent JB (1996) A biologically active form of chromium may activate a membrane phosphotyrosine phosphatase (PTP). Biochemistry 35, 12963–12969.
Davis CM & Vincent JB (1997) Chromium oligopeptide activates insulin receptor kinase activity. Biochemistry 36, 4382–4385.
Doisy RJ, Streeten DHP, Souma DHP, Kalafer ME, Rekant SL & Dalakos TG (1971) Metabolism of chromium 51 in human subjects. In Newer Trace Elements in Nutrition, pp.155–168 [W Mertz and WE Cornatzer editors]. New York, NY: Marcel Dekker.
Ekstrand AV, Eriksson JG, Gronhagen-Riska C, Ahonen PJ & Groop LC (1992) Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man. Transplantation 53, 563–569.
Evock-Clover CM, Polansky MM, Anderson RA & Steele NC (1993) Dietary chromium supplementation with or without somatotropin treatment alters serum hormones and metabolites in growing pigs without affecting growth performance. Journal of Nutrition 123, 1504–1512.
Faul JL, Tormey W, Tormey V & Burke C (1998) High dose inhaled corticosteroids and dose dependent loss of diabetic control. British Medical Journal 317, 1491.
Institute of Medicine Staff (2001) Dietary Reference Intakes for VitaminA, Vitamin|K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc, pp.197–223. Washington, DC: National Academy Press.
Jain SK & Kannan K (2001) Chromium chloride inhibits oxidative stress and TNF–alpha secretion caused by exposure to high glucose in cultured U937 monocytes. Biochemical and Biophysical Research Communications 289, 687–691.
Jovanovic L, Gutierrez M & Peterson CM (1999) Chromium supplementation for women with gestational diabetes mellitus. Journal of Trace Elements in Experimental Medicine 12, 91–98.
Kaats GR, Blum K, Fisher JA & Adelman JA (1996) Effects of chromium picolinate supplementation on body composition: a randomized double–masked placebo–controlled study. Current Therapeutic Research 57, 747–756.
Kandror KV (1999) Insulin regulation of protein traffic in rat adipose cells. Journal of Biological Chemistry 274, 25210–25217.
Kern PA, Ranganathan S, Li C, Wood L & Ranganathan G (2001) Adipose tissue tumor necrosis factor and interleukin–6 expression in human obesity and insulin resistance. American Journal of Physiology 280, E745–E751.
Kim DS, Kim TW, Park IK, Kang JS & Om AS (2002) Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body weight in dexamethasone–treated rats. Metabolism 51, 589–594.
Kozlovsky AS, Moser PB, Reiser S & Anderson RA (1986) Effects of diets high in simple sugars on urinary chromium losses. Metabolism 35, 515–518.
Kraegen EW, Cooney GJ, Ye J & Thompson AL (2001) Triglycerides, fatty acids and insulin resistance – hyperinsulinemia. Experimental and Clinical Endocrinology and Diabetes 109, S516–S526.
Lopez-Candales A (2001) Metabolic syndrome X: a comprehensive review of the pathophysiology and recommended therapy. Journal of Medicine 32, 283–300.
Mandali SL, Stoecker BJ, Maxwell CV, de Rodas BZ & Arquitt AB (2002) Endotoxin decreases 51CrCl3 uptake in early weaned pigs. Biological Trace Element Research 88, 145–151.
Mertz W, Abernathy CO & Olin SS (1994) Risk Assessment of Essential Elements. Washington, DC: ILSI Press.
Morris BW (1999) Chromium action and glucose homeostasis. Journal of Trace Elements in Experimental Medicine 12, 61–70.
Morris BW, Blumsohn A, MacNeil S & Gray TA (1992) The trace element chromium – a role in glucose homeostasis. American Journal of Clinical Nutrition 55, 989–991.
Morris BW, MacNeil S, Hardisty CA, Heller S, Burgin C & Gray TA (1999) Chromium homeostasis in patients with type II (NIDDM) diabetes. Journal of Trace Elements in Experimental Medicine 13, 57–61.
Morris BW, Samaniego S, Fraser R & MacNeil S (2000) Increased chromium excretion in pregnancy is associated with insulin resistance. Journal of Trace Elements in Experimental Medicine 13, 389–396.
Pagano G, Bruno A, Cavallo-Perin P, Cesco L & Imbimbo B (1989) Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Prednisone, deflazacort, and betamethasone. Archives of Internal Medicine 149, 1098–1101.
Ravina A, Slezak L, Mirsky N & Anderson RA (1999a) Control of steroid-induced diabetes with supplemental chromium. Journal of Trace Elements in Experimental Medicine 12, 375–378.
Ravina A, Slezak L, Mirsky N, Bryden NA & Anderson RA (1999b) Reversal of corticosteroid–induced diabetes mellitus with supplemental chromium. Diabetic Medicine 16, 164–167.
Rubin MA, Miller JP, Ryan AS, Treuth MS, Patterson KY, Pratley PE, Hurley BF, Veillon C, Moser-Veillon P & Anderson RA (1998) Acute and chronic resistive exercise increase urinary chromium excretion in men as measured with an enriched chromium stable isotope. Journal of Nutrition 128, 73–78.
Stojanovska L, Rosella G & Proietto J (1990) Evolution of dexamethasone–induced insulin resistance in rats. American Journal of Physiology 258, E748–E756.
Striffler JS, Polansky MM & Anderson RA (1998) Dietary chromium decreases insulin resistance in rats fed a high-fat, mineral–imbalanced diet. Metabolism 47, 396–400.
Striffler JS, Polansky MM & Anderson RA (1999) Overproduction of insulin in the chromium-deficient rat. Metabolism 48, 1063–1068.
Sun Y, Ramirez J, Woski SA & Vincent JB (2000) The binding of trivalent chromium to low-molecular-weight chromium-binding substance (LMWCr) and the transfer of chromium from transferrin and chromium picolinate to LMWCr. Journal of Biological Inorganic Chemistry 5, 129–136.
Tuman RW & Doisy RJ (1977) Metabolic effects of the glucose tolerance factor (GTF) in normal and genetically diabetic mice. Diabetes 26, 820–826.
Vincent JB (2000) The biochemistry of chromium. Journal of Nutrition 130, 715–718.
Yamamoto A, Wada O & Suzuki H (1988) Purification and properties of biologically active chromium complex from bovine colostrum. Journal of Nutrition 118, 39–45.